🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
NBP
$NBP
🔒 US EquitiesNovaBridge Biosciences
AVG HISTORICAL GAP
+0.01%
MAX GAP RECORD
-6.85%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $NBP
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$NBP
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 11, 2026 Earnings Release 2026-08-11 (AFTER CLOSE) |
+0.54%
|
| Apr 07, 2026 Earnings Release 2026-04-07 (AFTER CLOSE) |
+5.65%
|
| Dec 18, 2025 Earnings Release 2025-12-18 (BEFORE OPEN) |
+1.94%
|
| Aug 20, 2025 Earnings Release 2025-08-20 (AFTER CLOSE) |
-3.10%
|
| Apr 03, 2025 Earnings Release 2025-04-03 (AFTER CLOSE) |
-6.85%
|
| Nov 14, 2024 Earnings Release 2024-11-14 (AFTER CLOSE) |
+1.87%
|
| Aug 28, 2024 Earnings Release 2024-08-28 (UNDETERMINED) |
+0.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.3%
Bullish Gaps (3)
Bearish Gaps (2)
Neutral / Flat (1)
📖 Intelligence Summary
NovaBridge Biosciences operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Rockville, MD.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗